CA3290161A1 - Dérivés de pyrido[4,3-d]pyrimidine utilisés comme inhibiteurs de la protéine mutante kras g12c pour le traitement du cancer - Google Patents

Dérivés de pyrido[4,3-d]pyrimidine utilisés comme inhibiteurs de la protéine mutante kras g12c pour le traitement du cancer

Info

Publication number
CA3290161A1
CA3290161A1 CA3290161A CA3290161A CA3290161A1 CA 3290161 A1 CA3290161 A1 CA 3290161A1 CA 3290161 A CA3290161 A CA 3290161A CA 3290161 A CA3290161 A CA 3290161A CA 3290161 A1 CA3290161 A1 CA 3290161A1
Authority
CA
Canada
Prior art keywords
pyrido
inhibitors
cancer
treatment
pyrimidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3290161A
Other languages
English (en)
Inventor
Philip A. Gerken
Snahel Patel
Monika J. WILLIAMS
Richard R. SURGENOR
Paul John Dransfield
Original Assignee
Frontier Medicines Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frontier Medicines Corp filed Critical Frontier Medicines Corp
Publication of CA3290161A1 publication Critical patent/CA3290161A1/fr
Pending legal-status Critical Current

Links

CA3290161A 2023-05-04 2024-05-03 Dérivés de pyrido[4,3-d]pyrimidine utilisés comme inhibiteurs de la protéine mutante kras g12c pour le traitement du cancer Pending CA3290161A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/464,191 2023-05-04
US63/615,742 2023-12-28

Publications (1)

Publication Number Publication Date
CA3290161A1 true CA3290161A1 (fr) 2024-11-07

Family

ID=

Similar Documents

Publication Publication Date Title
CA3267196A1 (fr) Dérivés de 4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-naphthalene-pyrido[4,3-d]pyrimidine en tant qu'inhibuteurs de l'oncoprotéine mutante kras(g12d) pour le traitement du cancer inhibiteurs de kras (g12d)
EP4247807A4 (fr) Inhibiteurs 6,7-dihydro-pyrano [2,3-d] pyrimidine du mutant kras g12c
IL308438A (en) Pyrido[3,4-D]pyrimidine compounds inhibit mutant KRAS proteins
WO2024229444A3 (fr) Inhibiteurs de kras mutante et leurs utilisations
CA3261000A1 (fr) Composés pyrido[4,3-d]pyrimidines
CA3261042A1 (fr) Inhibiteurs macrocycliques de kras pour le traitement du cancer
MXPA05013349A (es) Derivados de 2-amino-pirimidina como inhibidores de quinasa raf.
UA99597C2 (ru) Пиримидилциклопентаны как ингибиторы акт протеинкиназ
JOP20190154A1 (ar) بنز أيزو ثيازول، أيزو ثيازولو [3، 4-b] بيريدين، كينازولين، فثالازين، بيريدو [2، 3-d] بيريدازين ومشتقات بيريدو [2، 3-d] بيريميدين على هيئة مثبطات kras g12c لمعالجة سرطان الرئة، أو سرطان البنكرياس أو سرطان القولون والمستقيم
TW200516079A (en) Isethionate salt of a selective CDK4 inhibitor
NZ744349A (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors
ZA202205900B (en) 5-(2-(2,5-difluorophenyl)pyrrolidin-1 -yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as trk kinase inhibitors for treating cancer
SG132683A1 (en) Imidazopyrazine tyrosine kinase inhibitors
IL288529A (en) History of imidazo[2,1-c]pyrimidine as prc2 inhibitors for cancer therapy
WO2009007749A3 (fr) Composés 947
WO2005051302A3 (fr) Inhibiteurs bicycliques de mek, et leurs procedes d'utilisation
NO20063231L (no) Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
MX2012001420A (es) Derivados de pirrolo[1,2-b]piridazina como inhibidores de cinasa janus.
EP4302761A3 (fr) Formes cristallines de (s)-1-(4-fluorophényl)-1-(2-(4-(6-(1-méthyl-1h-pyrazol-4-yl))pyrrolo[2,1-f][1,2,4]triazin-4-yl)pipérazinyl)-pyrimidin-5-yl)éthan-1-amine et des procédés de fabrication
AU2003242860A1 (en) 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders
CA3266687A1 (fr) Dérivés pyrazolo[1,5-a]pyridine et imidazo[1,2-a]pyridine en tant qu’inhibiteurs de fgfr3 pour le traitement du cancer
EP4267581A4 (fr) Composés imidazo[1,5-b]pyridazine substitués servant d'inhibiteurs de kinase et leur utilisation
PH12019500478A1 (en) 8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereof
WO2005021510A3 (fr) Heterocycles c-2 benzimidazole servant d'inhibiteurs de kinase